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A combinatorial approach using a One-Bead-One-Compound 
method and a screening based on an SOD-activity assay was set up 
for the discovery of an efficient peptidyl copper complex. The 
complex exhibited good stability constants, suitable redox 
potentials and excellent intrinsic activity. This complex was 
further assayed in cells for its antioxidant properties and showed 
beneficial effect when cells were submitted to oxidative stress. 
Among catalytic drugs,
1,2
 superoxide dismutase mimics 
(SOD mimics), able to catalytically dismutate superoxide into 
H2O2 and O2 (1), are of particular interest since oxidative 
stress, which results from an imbalance between reactive 
oxygen species (ROS) concentration and antioxidant defences, 
is involved in many pathologies.
3
 SOD mimics have been 
developed for the last three decades
3–5,6
 for their biological 
and therapeutic applications.
7
 Most of them are complexes 
involving an organic ligand and metal ions such as iron, 
manganese or copper to perform the redox dismutation of the 
superoxide anion. One of the main parameters to be 
controlled for a good SOD-activity is the redox potential of 
metal ions couple involved. Its value should be between the 
redox potentials of O2
—/O2 and H2O2/O2
—, an optimal value 
being the mid-point of these two potentials at physiological 
pH.
6,8,9
 
2O2
— + 2H+  H2O2 + O2      (1) 
 Peptide-based SOD mimics have also been extensively 
explored.
10–16
 Peptidyl ligands are valuable since their 
synthesis on solid support is easy and very versatile; they are 
biocompatible, easily metabolized and they can be conjugated 
to vector. However, the rational design of the peptide 
sequence to obtain a thermodynamically stable complex with 
the adequate redox potential still remains a challenge. To 
tackle these obstacles, a valuable alternative is the use of a 
combinatorial approach.
17,18
 Using a one-bead-one-compound 
(OBOC) method, a large panel of rather small peptides (less 
than 20 amino acids) can be easily produced, allowing the 
exploration of a vast and flexible structure and reactivity 
space. Examples of bioactive peptidyl complexes found by 
combinatorial chemistry are very scarce and, to the best of our 
knowledge, such approach has never been applied for the 
discovery of peptide-based redox active complexes including 
those mimicking SOD activity.
19
 In this context, we have 
designed a strategy associating the preparation of a 
combinatorial library of peptidyl metal complexes on solid 
support with a screening involving an activity-based assay with 
an easy-to-analyse read-out for the discovery of new efficient 
SOD mimics. The activity assay is inspired from the functional 
assay used to characterize SOD on electrophoretic gels.
20
 This 
leads to the selection of a hit complex that has been 
synthesized on a larger scale, characterized in details and 
studied on cellular models of oxidative stress which is 
unprecedented for peptidyl metal complexes. 
 To generate the library of peptidyl ligands, the design of 
the sequence has been inspired by the natural copper-zinc 
SOD which exhibits three to four imidazoles from histidines 
bound to the copper metal ion at its active site.
21
 The design of 
the sequence we have chosen to explore rely on a combination 
of the three most efficient Cu
2+
 binding motifs HXHH, HXHXH 
and HXXHXXH leading to the sequence Ac-X1H2H3X4H5H6X7H8 
with X not being a histidine. To increase the chemical space 
and favour the formation of a Cu complex with an adequate 
redox potential, we have applied a guided combinatorial 
approach with a screening based on the anti-superoxide 
activity. We have chosen to introduce variability on the 
second, third and sixth positions in this sequence introducing 
amino acids other than a histidine, either coordinating or non-
coordinating. Hence, aspartate, glutamate or tyrosine were 
chosen as coordinating amino acids but also non-coordinating 
amino acids (glycine and arginine) to possibly provide flexibility 
and charge variation. Only histidines were chosen for the fifth 
and eighth positions to increase the occurrence of Nim in the 
coordination sphere. Finally, lysine was added at the fourth 
position to increase water solubility, while proline and leucine 
were chosen at first and seventh positions respectively as non-
coordinating amino acids acting as spacers. The N-terminal 
amino functions were acetylated to avoid any binding of the 
metal ion from the free terminal amine. This design of this 
216-members library led to the general sequence Ac-
  
PZ1Z2KHZ3LH-OH where Zn corresponds to the positions where 
diversity has been introduced. 
 
Figure 1. a) Schematic representation of the library on bead. b) Work flow of 
the Gel SOD assay screening: the resin (50 mg) is incubated in a CuSO4 
solution (50 mM, 1 mL). The gel was submitted to UV irradiation and active 
beads were collected. Peptide were cleaved from the resin in basic 
conditions and the sequences were determined by MALDI-TOF mass 
spectrometry. ANP stands for 3-amino-3-(2-nitrophenyl)propanoic acid and 
HMBA for 4-hydroxymethylbenzoic acid. 
 Inspired by B. Imperiali’s work
22
 related to the discovery of 
lanthanide binding tag, a split and mix approach on solid 
support associated with a assay on gel has been employed 
using a classical Fmoc strategy (SI, Scheme S1). Two kinds of 
linkers have been grafted before the synthesis of the peptides: 
(a) 10% of a photocleavable linker (ANP) to release the 
peptides upon UV irradiation, enabling a clearer identification 
of active complexes, and (b) 90% of 4-hydroxymethylbenzoic 
acid (HMBA), which is only released in basic conditions (Figure 
1a).
22
 A mass increasing sequence (GRPPA), which adopts a 
random conformation has also been introduced to the 
construct to facilitate the further MALDI-TOF mass 
spectrometry analysis.
23
 As in all combinatorial libraries of 
peptides, isobaric sequences of peptides have been generated. 
In order to identify unambiguously the peptides by a simple 
mass spectrometry analysis, the strategy developed by 
Griesinger and coworkers and modified by Imperiali’s group 
has been applied (see SI for more details).
22,23
 After peptide 
side chains deprotection with trifluoroacetic acid, beads were 
incubated with CuSO4, washed and immobilized in an agarose 
gel. The bioactivity assay involved the production of 
superoxide ions through UV irradiation of riboflavin.
20
 
Nitroblue tetrazolium (NBT), a yellow reactant, was added to 
the mixture as a colour-marker of the superoxide anion 
production since it reacts specifically with superoxide to give 
the purple formazan. In this assay, active complexes compete 
with NBT to react with the superoxide ion, precluding the 
formation of formazan. As a consequence, a yellow colour was 
an indication of an active complex bore by that bead, as 
opposite to a purple colour for an inactive complex (Figure 1b). 
During UV irradiation, a small fraction of the complexes bound 
to the bead with the photocleavable linker was released and 
diffused around the bead in the gel. This allowed to widen the 
area around the beads where no reaction with the NBT 
occurred, thus facilitating the naked-eye observation. Doing 
so, a high number of beads showed a positive result. To get 
more selectivity based on the thermodynamic stability of the 
complexes, we have thus increased the selective pressure on 
the complex stability by washing the beads with EDTA (50 mM, 
pH 8), a very competitive ligand for Cu
2+
 (log(EDTA-Cu) = 
18.8).
24
 This additional washing step allowed to remove the 
more loosely bound copper ions and/or to release the copper 
from complexes that are not kinetically inert within the 
washing period. To note, this step does not ensure that the 
remaining complexes are more stable or inert than EDTA-Cu 
complex since contributions from the confinement and 
accessibility due to the solid support may participate to the 
complexes stability and inertness. After washing, only 5% of 
the beads have shown a positive result. The beads that 
support active complexes were isolated from the gel, the 
peptide cleaved from the bead in basic conditions, and the 
sequences were analysed by MALDI-TOF mass spectrometry 
(Figure S1). About 1200 beads were assayed (each sequence 
being potentially tested 5 times) among which 20 complexes 
showed activity and, the sequence PDHKHHLH was found four 
times (Tables S1 and S2), consequently, the peptide: Ac-
PDHKHHLH-NH2 (called OCP1) was selected for further 
investigations. 
 The OCP1-Cu
2+
 complex was fully characterized in solution 
using a panel of techniques. All the data are reported in the 
Table 1 and in the supporting information. A titration with 
Cu(ClO4)2 by potentiometry combined with UV-vis and circular 
dichroism spectroscopies showed that three Cu species 
predominate in solution for a 1:1 OCP1:Cu mixture at 
physiological pH. Two species possess 3 Nim and 1 
deprotonated amide (N
-
) and differ only from the protonation 
state of a non-coordinating imidazole and the third species 
involves 2 Nim and 2 N
-
 in the Cu
2+
 coordination sphere (SI 
Figures S2-7). The apparent dissociation constant (KD = 1.2  
0.1 10
-10
) at pH 7.4 (HEPES, 50 mM) was determined by a 
competition experiment.25 (SI, Figure S8). This value is in good 
agreement with the best apparent constant found for other 
peptidyl copper complexes mimicking SOD. To be an efficient 
catalyst for superoxide dismutation, the copper ion has to 
cycle between the two redox states Cu
+
 and Cu
2+
. 
Consequently, to ensure a catalytic activity with several 
turnovers, the peptide-Cu
+
 complex must be stable as well in 
physiological conditions. Thus, the coordination sphere with 
Cu
+
 was also studied by 
1
H NMR spectroscopy as previously 
performed in another context.
26
 Histidine protons are the 
most affected by the presence of Cu
+
 (Figure S9) and no 
significant changes were observed for the aspartate proton 
signals or those from the backbone amides. The coordination 
of Cu
+
 seems therefore to involve only Nim. A competition 
experiment was also performed to determine the apparent 
dissociation constant of OCP1 for Cu
+
 (KD,Cu
+
 = 6.0  0.4 10
-9
) 
(SI, Figure S10).
27
 
 Important features of SOD mimic catalysts rely on their 
redox behaviour. To be efficient, the system has to be 
reversible, fast and the redox potentials of the complex must 
be comprised between the redox potentials of the two couples 
O2
-/H2O2 and O2/O2
- (0.92 V/NHE and -0.18 V/NHE, 
respectively) with an optimal value at the mid-point 0.36 
  
V/NHE.
6,8,9,28
 The redox behaviour of OCP1-Cu was examined 
by cyclic voltammetry (Table 1, Figure S11) and was found 
poorly reversible as the difference between the anodic and 
cathodic redox potentials is approximatively 600 mV. This can 
be explained by a structure reorganization of the complexes 
when oscillating between the two redox states Cu
+
 and Cu
2+
, a 
reminiscent behaviour of peptide or peptide-like Cu
2+
/Cu
+
 
complexes.
29,30
 The values of the redox potentials (Epa = 0.55 
V/NHE and Epc = -0.05 V/NHE) at physiological pH for the 1:1 
copper/ligand complex are indeed suitable for the efficient 
dismutation of the superoxide ion. 
Table 1. Thermodynamic and kinetics constants of representative Cu2+ complexes 
involving a peptidyl ligand. 
Ligand L 
L/Cu ratio 
IC50 
(µM) 
kappMCF
g 
(M-1s-1) 
E
 
(V) /NHE 
Coordination 
sphere 
Reference 
OCP1      
1/1 0.124
a
 2.3.10
7
 
Epa = 0.55 
Epc = -0.05 
3Nim,1N
-
 
and 2Nim, 2N
- 
this article 
5/1 0.060 a 4.8.107    
Ac-HVH-NH2       
1/1 
0.160b 
0.160
a
 
1.5.10
7
  2Nim, 2N
-
 
31 
this article 
cHH-OH      
2/1 0.500c 4.8.107  4Nim
 13,32 
Ac-HHGH-OH      
1/1 
0.130d 
0.150e 
2.2.107 
2.0.107 
 
3Nim,OH
-or  
2Nim,N
-,H2O 
10,14  
10/1 0.250e 1.2.107    
HADHDHKK-NH2   
    
1/1 0.110c 2.7.107  3Nim, NH2term 33 
Ac-HAAHGH-NH2      
1/1 0.048f 6.2.107 E1/2 = 0.33 2Nim, N
- 10 
CuZnSOD 0.0016 a 1.8.109 E1/2 = 0.12-0.3 4 Nim 
this article, 
14,28,34 
CuSO4 0.603
 a 4.8.106   this article 
a XTT (100 µM) in HEPES buffer (50 mM, pH 7.5). b NBT (50 µM) in Tris buffer (20 mM, 
pH 7.4). c Cytochrome C (50 µM) in phosphate buffer (50 mM, pH 7). d NBT (50 µM) in 
phosphate buffer (50 mM, pH 6.8). e NBT (50 µM) in phosphate buffer (50 mM, pH 7.5). 
f NBT (50 µM) in phosphate buffer (50 mM, pH 7.4). h Catalytic constants calculated 
from the IC50 are apparent since they are calculated from a mixture of species (several 
copper complexes and potentially free copper). 
 Intrinsic SOD-activity that refers to the kinetics of the 
reaction with superoxide,
6
 was investigated through the 
McCord and Fridovich assay using xanthine/xanthine oxidase 
as source of superoxide and XTT as UV-vis marker of 
superoxide production. This assay lead to the determination of 
the IC50 and the corresponding apparent catalytic constant 
kappMCF. The apparent IC50 of the OCP1-Cu 1:1 complex was 
estimated at 124 nM, which corresponds to an apparent 
catalytic constant of kappMCF = 2.4.10
7
 M
-1
s
-1
 (See SI for more 
details). Under these conditions, 1 complex reacts with at least 
6 superoxide molecules, showing that the complex is able to 
cycle for catalysis. Its activity represents 1.3% of the activity of 
CuZnSOD enzyme in the same conditions.
6,9
 These results at 
pH 7.5 are consistent with the best catalytic constants found 
for peptide-based copper SOD mimics (Table 1).
33
 It has been 
controlled that hydrogen peroxide, produced continuously 
under Fridovich experiment, has no significant effect on the 
complex OCP1-Cu SOD activity (IC50 = 110 nM in presence of 
catalase to be compared to 124 nM without catalase, Figure 
S12). Upon increasing the ligand to metal ratio, the IC50 
decreases and reaches a plateau (at ca 60 nM) from a ratio 
OCP:Cu 5:1, more likely because of the equilibrium shifting 
towards complex formation (Figure S13). To validate the 
screening strategy, a peptidyl (Ac-PHYKHRLH-NH2) copper 
complex that belongs to the used library and exhibits a similar 
dissociation constant (5.5  1 10
-10
) and that has not been 
selected during the gel screening, has shown an IC50 three time 
higher that the OCP1-Cu (372 nM vs. 124 nm) (Figure S14). This 
strongly supports the fact that only the most active complexes 
are selected.  
 
Figure 2. Superoxide dismutase activity on Raw 264.7 macrophages. The 
extracellular concentration of superoxide is measured by UV-vis spectroscopy 
using XTT as UV-vis marker (470 nm). The absorbance measured for activated 
cells was arbitrary set at 100%. Data represent mean  SEM for five independent 
experiments. (*) p < 0.05, (**) p < 0.01, (***) p < 0.001 vs. activated cells and n s 
means non-significant. 
 The 1:1 mixture was tested in more relevant biological 
conditions, namely on cellular models. Murine macrophages 
Raw 264.7, which is a cellular model of oxidative stress, has 
been selected for that purpose.
35,36
 On this cell line, the 
production and excretion of ROS in the extracellular medium, 
including superoxide, can be induced using lipopolysaccharide 
(LPS), interferon (IFN-) and phorbol myristate acetate 
(PMA). The superoxide production was measured using the 
UV-vis marker XTT after incubation of the complexes at 
different non-toxic concentrations (toxicity data in Figure S15) 
for 1 hr. One hour was enough to induce the release of a 
significant amount of superoxide into the extracellular medium 
leading to very reproducible data (Figure S16). The results with 
the complex OCP1-Cu 1:1 clearly showed a dose-dependent 
effect (Figure 2). The peptidyl ligand showed no effect on 
superoxide production. Interestingly, incubation with the Cu
2+
 
salt induced a decrease in formazan formation to a weaker 
extent than OCP1-Cu at the same concentration. Since it has 
been suggested that the cellular reduction of the cell-
impermeable XTT may also involve trans-plasma membrane 
electron transport
37
 and not only reduction by superoxide, the 
reduced formazan production observed upon incubation of 
CuSO4 may also be due to its interference with this pathway. 
Consequently, the same assay has been performed using 
ferricytochrome c which is more selective for superoxide.
35
 
OCP1-Cu 1:1 showed, as for XTT, a dose-dependent effect. Its 
activity at 5 M was similar to that of the natural SOD at 100 U 
mL
-1
 (Figure S17-S18). In this case, neither the Cu
2+
 salt nor the 
peptidyl ligand showed an effect on the superoxide 
concentration, highlighting the need for the formation of the 
complex for a SOD activity in that context. 
  
The 1:1 complex was further investigated for its 
intracellular SOD-like activity on a cellular model (HT29-MD2) 
for which an inflammation mediated by oxidative stress can be 
induced.
38
 On this cell line, OCP1-Cu 1:1 complex and the 
ligand were found non-toxic up to 100 µM whereas copper 
sulphate was not toxic at 10 µM but toxic at 100 µM (Figure 
S19). At 100 µM, the fact that the complex was not toxic, 
whereas CuSO4 was, constitutes an indirect proof that the 
complex was at least partially stable in this experiment. Cells 
were incubated with the compounds at non-toxic 
concentrations, activated with LPS and the inflammatory 
marker interleukine 8 (IL8) was measured. As expected, upon 
activation, an increase in IL8 production was measured and 
this production was decreased only after incubation of the 
complex at 100 µM. Neither the free ligand, nor the copper ion 
(at 10 µM) were found able to reduce this inflammation 
marker (Figure 3). These results suggest that the Cu complex is 
the active species. The recombinant CuZnSOD enzyme, which 
is catalytically very efficient but unable to penetrate cells, did 
not lead to a reduced IL8 concentration, suggesting that the 
antioxidant molecule needs to be internalized to exert its 
activity. All together, these results show that the selected 
complex is able to penetrate cells where it exerts its 
antioxidant activity leading to an interesting anti-inflammatory 
activity. So far, it is the first time that a peptidyl complex 
mimicking SOD activity has been successfully described in a 
cellular assay. 
 
Figure 3. Quantification of the inflammatory marker IL8 by ELISA after incubation on 
epithelial cells HT29-MD2 (3h, 37°C in HEPES (0.1M, pH 7.5, glucose (1 g.L-1)). Dose 
effect of OCP1-Cu complex. The absorbance measured for activated cells is arbitrary set 
at 100%. Data represent mean  SEM for two independent experiments. 
In conclusion, we have demonstrated that combining 
rationally design combinatorial library of peptidyl metal 
complexes and an activity- based assay enables the discovery 
of very efficient and stable catalysts for the desired biomimetic 
activity. The hit SOD mimic peptidyl complex was fully 
characterized and exhibited the expected properties. More 
interestingly, this complex showed anti-inflammatory 
properties in a cellular model with an oxidative stress 
mediated inflammation. These results open up new 
opportunities for the development of efficient and stable 
peptidyl metal complexes that can be used as catalytic drugs. 
In addition, this innovative combinatorial design associated 
with an activity based-assay is a strategy that can be used for 
many others activities as soon as an activity-based assay can 
be implemented. 
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